All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @alexusdevon on TikTok · 57s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @alexusdevon's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00It's been three months on my semi-glute high journey
  2. 0:02and it's injection day, so let's go ahead
  3. 0:04and do the injection.
  4. 0:05So my hands are already clean and sanitized
  5. 0:07and I've been doing my arms,
  6. 0:09but we're gonna switch it back and go back to the stomach.
  7. 0:11So we have the stomach of course
  8. 0:14and we're just gonna clean it off and sanitize it.
  9. 0:19And now we have our pin and we're just gonna remove the cap.
  10. 0:29So we're good there, we finished it
  11. 0:32and now we can go ahead and place our used pin
  12. 0:35and our PRA Sharp Disposable Container
  13. 0:37which is super easy to use.
  14. 0:39Just place it right here, close it.
  15. 0:43And guess what, when we're all done with it,
  16. 0:44we can just go ahead and place the used container
  17. 0:47back in our PRA shipping box.
  18. 0:50This is the most easiest, efficient
  19. 0:52and eco-friendly system you can use
  20. 0:54when it's buzzing out of your used pins and needles.
  21. 0:57So we're gonna need to do the same thing.

@alexusdevon's routine GLP-1 claims, fact-checked

Lex 🦋

TikTok creator

145.9K viewsWatch on TikTok →

Quick answer

The creator demonstrates subcutaneous semaglutide self-injection with site rotation from arm to abdomen and immediate disposal into a mail-back sharps container. Both site rotation to prevent lipohypertrophy and proper sharps disposal are clinically appropriate practices for patients self-administering GLP-1 receptor agonist pen medications at home. No dosing information, therapeutic claims, or comparisons between compounded and brand-name formulations were made in this video.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @alexusdevon's routine GLP-1 claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

Compounded Semaglutide should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

After comparing, use the get-started flow to route your goals and health history into the right prescription review path.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@alexusdevon's routine GLP-1 claims, fact-checked" from Lex 🦋. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator demonstrates subcutaneous semaglutide self-injection with site rotation from arm to abdomen and immediate disposal into a mail-back sharps container.

The reason this review is not generic is the source wording and the canonical claim label "glp1 routine just got easier with pureway glp1community glplj." In this clip, the useful excerpt is: "It's been three months on my semi-glute high journey and it's injection day, so let's go ahead and do the injection." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Mail-back sharps disposal is a legitimate FDA-recognized option, but free community drop-off programs at pharmacies exist in most U.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator demonstrates subcutaneous semaglutide self-injection with site rotation from arm to abdomen and immediate disposal into a mail-back sharps container.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator demonstrates subcutaneous semaglutide self-injection with site rotation from arm to abdomen and immediate disposal into a mail-back sharps container. Both site rotation to prevent lipohypertrophy and proper sharps disposal are clinically appropriate practices for patients self-administering GLP-1 receptor agonist pen medications at home. No dosing information, therapeutic claims, or comparisons between compounded and brand-name formulations were made in this video.
  • Rotating subcutaneous injection sites is clinically required, not optional. Hirsch et al. (2014, Diabetes Care) showed lipohypertrophy from repeated same-site injection measurably reduces drug absorption.
  • Mail-back sharps disposal is a legitimate FDA-recognized option, but free community drop-off programs at pharmacies exist in most U.S. states and may be more accessible.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • Rotating subcutaneous injection sites is clinically required, not optional. Hirsch et al. (2014, Diabetes Care) showed lipohypertrophy from repeated same-site injection measurably reduces drug absorption.
  • Mail-back sharps disposal is a legitimate FDA-recognized option, but free community drop-off programs at pharmacies exist in most U.S. states and may be more accessible.
  • Tossing used pen needles in household trash is illegal in several U.S. states and exposes sanitation workers to needle-stick and bloodborne pathogen risk.
  • The abdomen 2 inches from the navel remains the most studied subcutaneous site for consistent GLP-1 absorption. Thigh and upper arm are acceptable but rotate across all three.
  • Semaglutide pens should be inspected before each injection. The solution should be clear and colorless. Cloudiness or particulates means do not inject and contact your pharmacy.
  • Allow refrigerated semaglutide pens to reach room temperature before injecting. Cold injections increase discomfort and may affect absorption in subcutaneous tissue.
  • No dose information or therapeutic claims were made in this video, which puts it well above average for responsible GLP-1 content on TikTok.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @alexusdevon actually say?

Three months into a semaglutide journey, the creator walked viewers through an injection on the stomach after switching from the arm, then disposed of the used pen in what they called a "PRA Sharp Disposable Container" that ships back when full. That is the core of the video. No dosing claims, no weight loss numbers, no medical advice. Just a procedural demo and a product plug for a mail-back sharps container.

To be clear: this is a sponsored-feeling post for a sharps disposal service called PureWay. The creator is enthusiastic, calling it "the most easiest, efficient and eco-friendly system." That framing deserves scrutiny, but the underlying message, dispose of your used needles properly, is one of the more responsible things a GLP-1 creator can actually say on TikTok.

Does the science back this up?

On sharps disposal, yes, broadly. The FDA and EPA both classify used insulin-type pen needles and autoinjector pens as household sharps, and improper disposal creates real injury and infection risk for sanitation workers. Mail-back programs are an FDA-recognized disposal method.

On rotating injection sites, also yes. Subcutaneous injections into the same spot repeatedly cause lipohypertrophy, a buildup of fatty tissue that impairs drug absorption. Famously documented in insulin users, the same principle applies to GLP-1 pens. Hirsch et al. (2014, Diabetes Care) found that lipohypertrophy at injection sites was associated with higher insulin variability and worse glycemic control. Rotating between abdomen, thigh, and upper arm is standard clinical guidance, and the creator is doing exactly that.

The alcohol swab step before injection is standard practice taught in clinical settings, though the evidence that it prevents infection in home settings is actually thinner than most people assume. Dann (1969, Lancet) noted minimal bacterial contamination risk in healthy skin, but the habit persists as a low-harm precaution.

What did they get wrong (or right)?

Honestly, they got more right than most GLP-1 TikToks. Site rotation: correct. Sharps disposal: correct and commendable. Sanitizing hands and skin: reasonable precaution.

What they got fuzzy: calling the sharps system "eco-friendly" is a marketing claim, not an established fact. Mail-back incineration programs reduce needle-stick injuries, but incineration has its own environmental footprint. The EPA does not categorically classify mail-back medical waste incineration as an environmental net positive. Viewers should not take that claim at face value without reading PureWay's own environmental disclosures.

The phrase "semi-glute high" is clearly a mispronunciation of semaglutide, not a medical error, but it is worth noting for the 145,000 viewers who might be new to the medication. The drug is semaglutide. Precision in naming matters when people are Googling what to ask their prescriber.

No red flags here from a safety standpoint. The creator did not mention dose, did not claim the drug cured anything, and did not compare compounded semaglutide to brand-name Ozempic or Wegovy.

What should you actually know?

If you are on a GLP-1 medication at home, sharps disposal is not optional, it is a legal and public health obligation in most U.S. states. Tossing used pen needles in the household trash is illegal in several states and exposes sanitation workers to needle-stick injuries and bloodborne pathogen risk.

Mail-back programs like PureWay are one legitimate option. Others include community sharps drop-off programs (often free at pharmacies), FDA-approved sharps containers for regular trash in permissive states, and household hazardous waste events. The FDA's Safe Sharps Disposal guidance covers all of these.

On injection technique: the abdomen, specifically the area two inches from the navel, remains the most studied subcutaneous site for consistent absorption. Thigh and upper arm are acceptable alternatives. The key is rotation within and across sites. If you notice a firm or lumpy area where you have been injecting, tell your prescriber. That is lipohypertrophy, and injecting into it reduces how much drug you actually absorb.

  • Always check your pen for particulates or cloudiness before injecting. Semaglutide solution should be clear and colorless.
  • Allow the pen to reach room temperature before use if stored in the refrigerator. Cold injections are more uncomfortable and may affect tissue absorption.
  • Do not recap needles by hand. Use a one-handed scoop method or drop directly into a sharps container.

Bottom line

This video is a sharps disposal product demo, not a medical tutorial, and it should be read that way. The creator did not make dangerous claims. The core behaviors shown, rotating sites, sanitizing, using a proper sharps container, are all aligned with clinical guidance. The "eco-friendly" claim is marketing language that has not been independently verified. And anyone new to semaglutide should confirm their own injection technique with their prescribing clinician, not a TikTok, however well-intentioned.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Lex 🦋 · TikTok creator

145.9K views on this video

Routine just got easier with @PureWay #glp1community #glpljourney #gIplforweightloss #weightloss #glp1medication #semaglutide #glp1journey

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about rotating subcutaneous injection sites?

Rotating subcutaneous injection sites is clinically required, not optional. Hirsch et al. (2014, Diabetes Care) showed lipohypertrophy from repeated same-site injection measurably reduces drug absorption.

What does the video say about mail-back sharps disposal?

Mail-back sharps disposal is a legitimate FDA-recognized option, but free community drop-off programs at pharmacies exist in most U.S. states and may be more accessible.

What does the video say about tossing used pen needles in household trash?

Tossing used pen needles in household trash is illegal in several U.S. states and exposes sanitation workers to needle-stick and bloodborne pathogen risk.

What does the video say about the abdomen 2 inches from the navel remains the most?

The abdomen 2 inches from the navel remains the most studied subcutaneous site for consistent GLP-1 absorption. Thigh and upper arm are acceptable but rotate across all three.

What does the video say about semaglutide pens should be inspected before each injection. the solution?

Semaglutide pens should be inspected before each injection. The solution should be clear and colorless. Cloudiness or particulates means do not inject and contact your pharmacy.

What does the video say about allow refrigerated semaglutide pens to reach room temperature before injecting.?

Allow refrigerated semaglutide pens to reach room temperature before injecting. Cold injections increase discomfort and may affect absorption in subcutaneous tissue.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Lex 🦋, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.